ALUULA Announces Closing of Upsized $14.1 Million Brokered LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2026-02-24 13:38

Core Viewpoint - ALUULA Composites Inc. has successfully completed a brokered private placement, raising C$14,102,467.50 through the sale of 4,273,475 units at C$3.30 each, with the proceeds aimed at expanding manufacturing capacity and general working capital [1][4]. Group 1: Offering Details - The offering consisted of units, each comprising one common share and one half of a common share purchase warrant, with the warrant allowing purchase of a common share at C$4.29 within 24 months [2]. - The offering was conducted by Canaccord Genuity Corp. as the sole agent, and included a cash commission of C$730,798.61 and 221,454 agent warrants [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for expanding manufacturing capacity, constructing a new facility, and covering general administrative costs, including repayment of a C$1,000,000 promissory note [4]. Group 3: Regulatory and Compliance - The units were offered under the listed issuer financing exemption, allowing distribution in Canada and the U.S. without a prospectus, and are not subject to resale restrictions for Canadian residents [5]. - The offering is subject to final acceptance by the TSX Venture Exchange [5]. Group 4: Insider Transactions - Concurrently, four directors exercised warrants and stock options, generating C$500,000 in proceeds and resulting in the issuance of 278,484 common shares [6]. - Ten directors and officers have entered into voluntary 180-day lock-up agreements to restrict selling during this period [6]. Group 5: Related Party Transactions - One subscriber in the offering is considered a related party, and the repayment of the promissory note to a related party is classified as a related party transaction under Multilateral Instrument 61-101 [7].

aTyr Pharma-ALUULA Announces Closing of Upsized $14.1 Million Brokered LIFE Offering - Reportify